## 

# 



## 

## 

|**Trustees:**|Professor Anton van der Merwe|
|---|---|
||Professor A N Barclay, DPhil|
||Dr Marion Brown|
||Dr Eva Gluenz|
||Professor Omer Dushek|
|**Charity number**|1135590|
|**Principal address**|Sir William Dunn SchoolofPathology|
||South Parks Road|
||Oxford|
||OX13RE|
|**Auditor**|Critchleys Audit LLP|
||Beaver House|
||23-38 Hythe Bridge St|
||Oxford|
||OX12EP|
|**Bankers**|CAF Bank Limited|
||25 Kings Hill Ave|
||Kings Hill|
||West Maling|
||ME19 4JQ|
|**Solicitors**|Knights Solicitors|
||Midland House|
||West Way|
||Oxford|
||OX2 0PH|
|**Investment advisors**|Oxford University Endowment Management|
||27 Park End Street|
||Oxford|
||OX11HU|





## 

## 

||**Page**|
|---|---|
|Trustees' report|1 -**2**|
|StatementofTrustees' responsibilities|3|
|Independent auditor's report|4-7|
|Statementoffinancial activities|8|
|Balance sheet|9|
|Statementofcash flows|10|
|Notes to the financial statements|11- 17|





## 

## 

## 

## 

## 

## 



## 

## 

## 




## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 




28/10/2022 



## 

|||**Unrestricted**|Unrestricted|
|---|---|---|---|
|||**funds**|funds|
||||as restated|
|||**2022**|2021|
||**Notes**|<br>£|£|
|**Income from:**||||
|Investments|**3**|114,939|80,088|
|Royalties|**4**|489,575|412,426|
||||--|
|**Total income**||604,514|492,514|
||||--|
|**Expenditure on:**||||
|Charitable activities|**5**|(1,855)|130,529|
|Net gains/(losses) on investments|**8**|165,413|372,750|
|**Net movement in funds**||771,782|734,735|
|Fund balances at 1 April 2021||2,934,215|2,199,480|
|**Fund balancesat31March 2022**||3,705,997|2,934,215|





## 

## 

## 

|||||**as restated**||
|---|---|---|---|---|---|
|||**2022**||**2021**||
||**Notes**|£|£|£|£|
|**Fixed assets**||||||
|Investments|**9**||3,143,484|2,428,071||
|**Current assets**||||||
|Debtors|**10**|501,059||420,908||
|Cash at bank andinhand||211,151||275,231||
|||--||--||
|||712,210||696,139||
|**Creditors: amounts falling due within**||||||
|**one year**|**11**|(104,730)||(101,712)||
|Net current assets|||607,480|594,427||
|**Total assets less current liabilities**|||3,750,964|3,022,498||
|**Creditors: amounts falling due after**||||||
|**more than one year**|**12**||(44,967)|(88,283)||
|||||-||
|**Net assets**|||3,705,997|2,934,215||
|||||--||
|**Income funds**||||||
|Unrestricted funds|||3,705,997|2,934,215||
|||||--||
||||3,705,997|2,934,215||





## 

## 

||||**as restated**||
|---|---|---|---|---|
||**2022**||**2021**||
|**Notes**|£|£|£|£|
|**Cash flows from operating activities**|||||
|Cash generated from operations||370,981|413,265||
|**Investing activities**|||||
|Purchaseofinvestments|(550,000)||(300,000)||
|Investment income received|114,939||80,088||
||-||||
|**Net cash used in investing activities**||(435,061)|(219,912)||
|**Net cash used in financing activities**|||||
|**Net (decrease)/increase in cash and cash**|||||
|**equivalents**||(64,080)|193,353||
|Cash and cash equivalentsatbeginningofyear||275,231|81,878||
|**Cash and cash equivalentsatendofyear**||211,151|275,231||





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
||**2022**|2021|
||£|£|
|Income from investments|113,728|80,075|
|Interest receivable|1,211|13|
||114,939|80,088|
||-||



## 

||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
|||asrestated|
||**2022**|2021|
||£|£|
|Royalties|489,575|412,426|





## 

## 

## 

## 

||**2022**|**2021**|
|---|---|---|
||£|£|
|Grants|4,203|128,274|
|Grant underspend|(11,625)||
|Governance costs|5,567|2,255|
||--||
||{1,855)|130,529|



## 

## 

||**2022**|**2021**|
|---|---|---|
||**Number**|**Number**|
|Total|||
|There werenoemployees whose annual remuneration was more than £60,000.|||
|**Net gains/(losses)oninvestments**|||
||**Unrestricted**|Unrestricted|
||**funds**|funds|
||**2022**|2021|
||£|£|
|Revaluationofinvestments|165,413|372,750|



## 



## 

## 

## 

## 

||**Investments**|
|---|---|
||£|
|**Cost or valuation**||
|At 1 April 2021|2,428,071|
|Additions|550,000|
|Valuation changes|165,413|
|At31March 2022|3,143,484|
||--|
|**Carrying amount**||
|At31March 2022|3,143,484|
|At31March 2021|2,428,071|



## 

|**10**|**Debtors**|||
|---|---|---|---|
||||**as restated**|
|||**2022**|**2021**|
||**Amounts falling due within one year:**|£|£|
||Accrued investment income|11,484|8,482|
||Accrued royalty income|489,575|412,426|
|||501,059|420,908|
||||--|
|**11**|**Creditors: amounts falling due within one year**|||
|||**2022**|**2021**|
|||£|£|
||Grants payable|99,930|100,392|
||Accruals and other creditors|4,800|1,320|
|||-||
|||104,730|101,712|
||||--|
|**12**|**Creditors: amounts falling due after more than one year**|||
|||**2022**|**2021**|
|||£|£|
||Grants payable|44,967|88,283|





## 

## 

## 

|**No**|**8/fwd2021**|**New 2021/22 AdjustmentsPaid2021/22**|**New 2021/22 AdjustmentsPaid2021/22**|**C/fwd 2022**|
|---|---|---|---|---|
|CIU04|51,401|(11,625)|(32,153)|7,623|
|CIU07|5,000|||5,000|
|CIU08|132,274|||132,274|
||188,675|(11,625)|(32,153)|144,897|



## 

##